SKI Activates Wnt/-Catenin Signaling in Human Melanoma1

A motorcycle is provided with a protective cage on the side portions of an engine. The cage has two side portions that are separated from one another and are coupled to a common bottom member which extends underneath and/or through the engine. The side portions are coupled to the sides of the motorcycle frame at coupling points. The cage provides a low profile protective barrier between the engine and the ground when the motorcycle is on its side and does not interfere with the rider who wants to perform stunts on the motorcycle. At least one of the coupling points on each side is provided with a projection, which projection has a replaceable cap.

[1]  L. Banks,et al.  Skip interacts with the retinoblastoma tumor suppressor and inhibits its transcriptional repression activity. , 2002, Nucleic acids research.

[2]  M. Herlyn,et al.  Melanoma development and progression: a conspiracy between tumor and host. , 2002, Differentiation; research in biological diversity.

[3]  M. Kühl,et al.  The LIM-only protein FHL2 interacts with β-catenin and promotes differentiation of mouse myoblasts , 2002, The Journal of cell biology.

[4]  J. Licht,et al.  The LIM-only Protein DRAL/FHL2 Interacts with and Is a Corepressor for the Promyelocytic Leukemia Zinc Finger Protein* , 2002, The Journal of Biological Chemistry.

[5]  N. Hayward,et al.  Pathways to melanoma development: lessons from the mouse. , 2002, The Journal of investigative dermatology.

[6]  Stephen L. Lessnick,et al.  β-Catenin–induced melanoma growth requires the downstream target Microphthalmia-associated transcription factor , 2002, The Journal of Cell Biology.

[7]  P. Einat,et al.  Nr-CAM is a target gene of the beta-catenin/LEF-1 pathway in melanoma and colon cancer and its expression enhances motility and confers tumorigenesis. , 2002, Genes & development.

[8]  Kazuhiro Takahashi,et al.  Melanocyte-specific Microphthalmia-associated Transcription Factor Isoform Activates Its Own Gene Promoter through Physical Interaction with Lymphoid-enhancing Factor 1* , 2002, The Journal of Biological Chemistry.

[9]  A. Nicholson,et al.  Mutations of the BRAF gene in human cancer , 2002, Nature.

[10]  Sridhar Ramaswamy,et al.  Bcl2 Regulation by the Melanocyte Master Regulator Mitf Modulates Lineage Survival and Melanoma Cell Viability , 2002, Cell.

[11]  Kazuhiro Takahashi,et al.  Microphthalmia‐associated transcription factor interacts with LEF‐1, a mediator of Wnt signaling , 2002, The EMBO journal.

[12]  Avri Ben-Ze'ev,et al.  The cadherin-catenin adhesion system in signaling and cancer. , 2002, The Journal of clinical investigation.

[13]  C. Wolf‐peeters,et al.  Loss of Membranous Expression of β-Catenin Is Associated with Tumor Progression in Cutaneous Melanoma and Rarely Caused by Exon 3 Mutations , 2002, Modern Pathology.

[14]  A. Bosserhoff,et al.  The transcriptional coactivator FHL2 transmits Rho signals from the cell membrane into the nucleus , 2002, The EMBO journal.

[15]  E. Medrano,et al.  Cytoplasmic localization of the oncogenic protein Ski in human cutaneous melanomas in vivo: functional implications for transforming growth factor beta signaling. , 2001, Cancer research.

[16]  S. Ishii,et al.  The Ski Protein Family Is Required for MeCP2-mediated Transcriptional Repression* , 2001, The Journal of Biological Chemistry.

[17]  H Clevers,et al.  The chromatin remodelling factor Brg‐1 interacts with β‐catenin to promote target gene activation , 2001, The EMBO journal.

[18]  P. Wade.  Transcriptional control at regulatory checkpoints by histone deacetylases: molecular connections between cancer and chromatin. , 2001, Human molecular genetics.

[19]  D. Helfman,et al.  Cytoskeletal changes in cell transformation and tumorigenesis. , 2001, Current opinion in genetics & development.

[20]  P. Sassone-Corsi,et al.  A Family of LIM-Only Transcriptional Coactivators: Tissue-Specific Expression and Selective Activation of CREB and CREM , 2000, Molecular and Cellular Biology.

[21]  B. Schäfer,et al.  Dral Is a P53-Responsive Gene Whose Four and a Half Lim Domain Protein Product Induces Apoptosis , 2000, The Journal of cell biology.

[22]  A. Sonnenberg,et al.  The LIM-only Protein DRAL/FHL2 Binds to the Cytoplasmic Domain of Several α and β Integrin Chains and Is Recruited to Adhesion Complexes* , 2000, The Journal of Biological Chemistry.

[23]  A. Moustakas,et al.  Role of Smad Proteins and Transcription Factor Sp1 in p21Waf1/Cip1 Regulation by Transforming Growth Factor-β* , 2000, The Journal of Biological Chemistry.

[24]  W. Pavan,et al.  Neural crest-directed gene transfer demonstrates Wnt1 role in melanocyte expansion and differentiation during mouse development. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[25]  C. Goding,et al.  Mitf from neural crest to melanoma: signal transduction and transcription in the melanocyte lineage. , 2000, Genes & development.

[26]  J. Campisi,et al.  Ski acts as a co-repressor with Smad2 and Smad3 to regulate the response to type beta transforming growth factor. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Kris Vleminckx,et al.  The p300/CBP acetyltransferases function as transcriptional coactivators of β‐catenin in vertebrates , 2000, The EMBO journal.

[28]  R. Schüle,et al.  FHL2, a novel tissue‐specific coactivator of the androgen receptor , 2000, The EMBO journal.

[29]  B. Pak,et al.  Tyrosinase-related protein 2 as a mediator of melanoma specific resistance to cis-diamminedichloroplatinum(II): therapeutic implications , 2000, Oncogene.

[30]  D. Raible,et al.  Direct regulation of nacre, a zebrafish MITF homolog required for pigment cell formation, by the Wnt pathway. , 2000, Genes & development.

[31]  K. Miyazono,et al.  c-Ski Acts as a Transcriptional Co-repressor in Transforming Growth Factor-β Signaling through Interaction with Smads* , 1999, The Journal of Biological Chemistry.

[32]  P. Morin,et al.  β‐catenin signaling and cancer , 1999 .

[33]  R. Weinberg,et al.  Interaction of the Ski Oncoprotein with Smad3 Regulates TGF-β Signaling , 1999 .

[34]  Qiang Zhou,et al.  The Ski oncoprotein interacts with the Smad proteins to repress TGFbeta signaling. , 1999, Genes & development.

[35]  S. Ishii,et al.  Ski is a component of the histone deacetylase complex required for transcriptional repression by Mad and thyroid hormone receptor. , 1999, Genes & development.

[36]  D. Rimm,et al.  Frequent nuclear/cytoplasmic localization of beta-catenin without exon 3 mutations in malignant melanoma. , 1999, The American journal of pathology.

[37]  E. Price,et al.  α-Melanocyte-stimulating Hormone Signaling Regulates Expression of microphthalmia, a Gene Deficient in Waardenburg Syndrome* , 1998, The Journal of Biological Chemistry.

[38]  Randall T. Moon,et al.  Control of neural crest cell fate by the Wnt signalling pathway , 1998, Nature.

[39]  L. Karnell,et al.  The National Cancer Data Base report on cutaneous and noncutaneous melanoma , 1998, Cancer.

[40]  H. Beug,et al.  Transformation of hematopoietic cells by the Ski oncoprotein involves repression of retinoic acid receptor signaling. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[41]  A. Sparks,et al.  Identification of c-MYC as a target of the APC pathway. , 1998, Science.

[42]  K P Fung,et al.  Molecular cloning and characterization of FHL2, a novel LIM domain protein preferentially expressed in human heart. , 1998, Gene.

[43]  J. J. Breen,et al.  LIM domains: multiple roles as adapters and functional modifiers in protein interactions. , 1998, Trends in genetics : TIG.

[44]  R. Nicol,et al.  Transcriptional Repression by v-Ski and c-Ski Mediated by a Specific DNA Binding Site* , 1998, The Journal of Biological Chemistry.

[45]  R. Nusse,et al.  β-catenin: a key mediator of Wnt signaling , 1998 .

[46]  A. E. Sippel,et al.  DNA binding and transcriptional activation by the Ski oncoprotein mediated by interaction with NFI. , 1997, Nucleic acids research.

[47]  A. Yang,et al.  Monoallelically Expressed Gene Related to p53 at 1p36, a Region Frequently Deleted in Neuroblastoma and Other Human Cancers , 1997, Cell.

[48]  C. Colmenares,et al.  Mice lacking the ski proto-oncogene have defects in neurulation, craniofacial, patterning, and skeletal muscle development. , 1997, Genes & development.

[49]  B. Schäfer,et al.  Subtractive cloning and characterization of DRAL, a novel LIM-domain protein down-regulated in rhabdomyosarcoma. , 1997, DNA and cell biology.

[50]  K. Kinzler,et al.  Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC−/− Colon Carcinoma , 1997, Science.

[51]  Paul Polakis,et al.  Stabilization of β-Catenin by Genetic Defects in Melanoma Cell Lines , 1997, Science.

[52]  M. Beckerle,et al.  Molecular dissection of a LIM domain. , 1997, Molecular biology of the cell.

[53]  N. Nomura,et al.  Expression of the c-ski proto-oncogene in human melanoma cell lines. , 1993, Melanoma research.

[54]  G. Edelman,et al.  Structure of a new nervous system glycoprotein, Nr-CAM, and its relationship to subgroups of neural cell adhesion molecules , 1991, The Journal of cell biology.

[55]  N. Nomura,et al.  Isolation of human cDNA clones of ski and the ski-related gene, sno. , 1989, Nucleic acids research.

[56]  D. Gerhard,et al.  Generation of transforming viruses in cultures of chicken fibroblasts infected with an avian leukosis virus , 1981, Journal of virology.

[57]  P. Meltzer,et al.  High frequency of BRAF mutations in nevi , 2003, Nature Genetics.

[58]  Jeffrey C. Murray,et al.  Loss of the SKI proto-oncogene in individuals affected with 1p36 deletion syndrome is predicted by strain-dependent defects in Ski−/− mice , 2002, Nature Genetics.